drugset / Trial / NCT05014607
Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients
Summary
The aim of this project is to provide personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 to individual patients with advanced solid and hematological malignancies without any approved treatment options.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Personalized multi-peptide vaccine | Vaccine | 200 ug | Subcutaneous |
| Subject | Personalized multi-peptide vaccine | Vaccine | 300 ug | Subcutaneous |
| Background | XS15 | Other / unclassified | — | Subcutaneous |
| Background | incomplete Freund's adjuvant | Other / unclassified | — | Subcutaneous |